Free Trial

Exponent, Inc. (NASDAQ:EXPO) Director Sells $100,076.48 in Stock

Exponent logo with Business Services background

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares of the company's stock, valued at $565,494.72. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Exponent Trading Up 1.6 %

EXPO stock traded up $1.59 during trading on Tuesday, hitting $98.21. 124,463 shares of the company's stock were exchanged, compared to its average volume of 245,354. The business has a 50-day moving average price of $107.96 and a two-hundred day moving average price of $101.07. The stock has a market capitalization of $4.98 billion, a price-to-earnings ratio of 47.44 and a beta of 0.69. Exponent, Inc. has a 52-week low of $68.70 and a 52-week high of $115.75.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.14%. The ex-dividend date of this dividend is Friday, December 6th. Exponent's payout ratio is 54.11%.

Analyst Upgrades and Downgrades

Separately, Truist Financial reissued a "buy" rating and issued a $120.00 target price (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

View Our Latest Stock Report on Exponent

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Bamco Inc. NY acquired a new position in Exponent in the first quarter valued at $25,904,000. Vanguard Group Inc. grew its stake in Exponent by 5.8% during the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider's stock worth $437,153,000 after buying an additional 291,047 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its position in Exponent by 6.5% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider's stock worth $441,414,000 after buying an additional 284,179 shares during the period. Assenagon Asset Management S.A. purchased a new stake in Exponent in the second quarter valued at approximately $22,050,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of Exponent in the third quarter valued at approximately $11,261,000. 92.37% of the stock is owned by hedge funds and other institutional investors.

About Exponent

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

Should you invest $1,000 in Exponent right now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar
Top 3 Stocks Under $20 with Strong Buy Ratings and Growth Potential
ISRG Stock Surges: AI and Healthcare Innovation at the Core

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines